Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19
Status:
Completed
Trial end date:
2021-03-09
Target enrollment:
Participant gender:
Summary
An early stage trial to check how safe and tolerable, as well as how the body handles
continuous daily use of Active IMP over 28 days in healthy volunteers to help with
coronavirus infection (COVID-19).